RPI Finance Trust is Director & 10% Owner at Epizyme, Inc. (EPZM). They have made 1 open-market trade across 1 company since 2022, most recently 2022-01-31.
CIK 0001793690
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $68.0M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EPZM | 31,833,334 | $46.8M |
Shares reported on the most recent Form 4, priced at the 2022-02-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EPZM | BUY | 2022-01-31 | 2022-02-01 | $1.50 | $68.0M | +19.0% | +12.4% | -49.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.